Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells

.

Source: OncoImmunology - April 13, 2019 Category: Cancer & Oncology Authors: Maria C. Ochoa Elisabeth Perez-Ruiz Luna Minute Carmen O ñate Guiomar Perez Inmaculada Rodriguez Aintzane Zabaleta Diego Alignani Myriam Fernandez-Sendin Ascension Lopez Aura Muntasell Miguel F. Sanmamed Bruno Paiva Miguel Lopez-Botet Pedro Berraondo Ign Source Type: research